#Isentress

A recent study of Dutch clinicians found that they generally did a good job of preventing drug-drug interactions.

Merck’s investigational hepatitis C treatment grazoprevir/elbasvir cured high rates of the virus among individuals coinfected with HIV.

Harvoni and the combination of Sovaldi and daclatasvir were the least likely to cause a severe reaction with the HIV regimens of a cohort of H...

Researchers presented results from various studies on hepatitis C treatment and care at a medical conference in Seattle.

People who coinfected with HIV and hepatitis C looking to take the HCV drug Olysio may need to change HIV medications to avoid drug-drug inte...

Harvoni yielded a 96 percent cure rate among people with genotype 1 of hepatitis C, as well as a small number of those with genotype 4.

Twelve weeks of Gilead Sciences newly approved Harvoni cured nearly all people with genotype 1 of hepatitis C who were coinfected with HIV in...

Gilead Sciences’ fixed-dose combination pill of Sovaldi (sofosbuvir) and the investigational ledipasvir, likely to receive FDA approval on Oct...

AbbVie?s ?3D? regimen has shown high cure rates in treating genotype 1 of hepatitis C among those coinfected with HIV, both with and without c...

Sovaldi (sofosbuvir) and ribavirin cured between 84 percent and 91 percent of people coinfected with HIV and genotypes 1 through 4 of hepatiti...

The Sovaldi/ledipasvir combination pill to treat hepatitis C does not have a clinically significant impact on five common HIV antiretrovirals.

Early results of Merck’s combination hepatitis C therapy showed comparable safety between those with or without HIV, plus near-perfect cure ra...

The FDA has approved revisions to the label of the antiretroviral Kaletra (lopinavir/ritonavir) in order to include new information on...

Long-term studies have found that Isentress is both safe and effective in suppressing HIV among adult patients coinfected with hepatitis B, C...

Important preliminary recommendations involving the use of hepatitis C protease inhibitors among people living with HIV are provided by U.S. D...

The odds of curing hep C are now better than ever.